Industry News

Suprepharmagroup partner plans a RMB 300 million creatine monohydrate project in Inner Mongolia, targeting 50,000 tons of annual capacity.

The European vitamin market remains under pressure, with most products trading near historical lows. Niacinamide is showing greater price resilience, while buyers continue to focus on short-term demand and inventory control.

China has published four recommended national standards for health supplement ingredients, covering broken Ganoderma lucidum spore powder, astaxanthin, Coenzyme Q10 and spirulina. Approved on September 28, 2026, the standards are scheduled to take effect on April 1, 2027, establishing clearer quality and testing benchmarks for these ingredients.

Peptide therapeutics are gaining importance in the global pharmaceutical industry. Growing demand for chronic disease treatments, patent expiries, advances in peptide synthesis and AI-assisted drug discovery are creating new opportunities for peptide APIs and pharmaceutical raw material suppliers.

The global high-end API market is entering a new phase of quality-led growth. Demand for specialty APIs, HPAPIs and complex pharmaceutical raw materials is increasing, while technology, GMP compliance, supply stability and manufacturing efficiency are becoming key factors in global API competition.